-
-
-
-
-
-
-
Royalty Pharma names Lucas Glass as head of artificial intelligence
-
-
-
-
-
-
-
Royalty Pharma reports $4.7 billion in transactions for 2025
-
-
-
-
-
-
-
Royalty Pharma (RPRX) PT Raised at TD Cowen; 'Best Ideas 2026: Unique Business'
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Royalty Pharma (RPRX)
-
-
-
-
-
-
-
Royalty Pharma plc (RPRX) Declares $0.22 Quarterly Dividend; 2.5% Yield
-
-
-
-
-
-
-
UBS Reiterates Neutral Rating on Royalty Pharma (RPRX)
-
-
-
-
-
-
-
TD Cowen on Pharma: '10 Events in 2025 That Could Change Practice, Alter Companies, Move Stocks'
-
443,355 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

